The Daily Raise/September 10, 2026
Funding round
CONNECTA Therapeutics raises €3.1M
CONNECTA Therapeutics (Spain) has raised €3.1M, announced on September 10, 2026. The company is Develops small-molecule treatments for central nervous system disorders. The round was led by Clave Capital, with participation from Inveready, CDTI Innvierte, Prous Institute for Biomedical Research.
CONNECTA Therapeutics closed a €3.1 million financing led by Clave Capital to complete its Phase IIa trial of CTH120 in Fragile X syndrome.
Company
CONNECTA Therapeutics
Amount
€3.1M (~$3.6M)
Round
Unknown
Sector
Biotechnology
Country
Spain
Announced
September 10, 2026
Track every raise, every day
This deal appeared in The Daily Raise, September 10, 2026. Get the next edition in your inbox.
Just raised too?
Turn your funding news into guaranteed media coverage while the momentum lasts.